Meyenburg Jason Patrick 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Sep 8, 2017
Insider Transaction Report
Form 4
Meyenburg Jason Patrick
Chief Commercial Officer
Transactions
- Purchase
Common Stock, Class A
2017-09-06$12.13/sh+4,000$48,500→ 30,228 total